Papers

Quality assurance in extemporaneously compounded formulations: a titration method for ursodeoxycholic acid

By Therese Kairuz, MPharm, PhD, Darren Svirskis, BPharm, Joana Myftiu, BPharm, Maryam Behayaa, BPharm, Dina Shahin, BPharm, Thilini Thrimawithana, BPharm, Adela Vidicki, BPharm, Sanjay Garg, MPharm, PhD

This article as a PDF (70K)

Therese Kairuz is senior lecturer in pharmacy at the School of Life Sciences, Queensland University of Technology, Australia

Darren Svirskis
Joana Myftiu
Maryam Behayaa
Dina Shahin
Thilini Thrimawithana
Adela Vidicki
were students at the time of the study

Sanjay Garg is associate professor and deputy head

all at the School of Pharmacy, University of Auckland, New Zealand

Correspondence to
Professor Sanjay Garg
e-mail s.garg@auckland.ac.nz

ABSTRACT

OBJECTIVE — To validate an acid-base titration method, adopted from the British Pharmacopoeia, for analysis of ursodeoxycholic acid (UA) in extemporaneously compounded formulations.

METHODS — Two different extemporaneously compounded formulations containing UA 15mg/ml, prepared from both pure drug and Actigall capsules were compared.

A series of titrations was carried out to validate the titration method, as per International Conference on Harmonisation (ICH) guidelines. The titration method was used to analyse the stability of the UA suspensions stored for six weeks under ICH accelerated stability conditions.

RESULTS —The titration method was found to be specific and accurate. Differences between the initial drug concentration of the two suspensions and the concentration after six weeks at accelerated stability conditions were statistically insignificant, indicating stability of the formulations.

CONCLUSION — A simple acid-base titration method adopted from the British Pharmacopoeia has been validated to determine UA content in extemporaneously compounded suspensions, and can be recommended for quality assurance testing in hospital pharmacy.